DK1937221T3 - Depotformulering til pralnacasan - Google Patents
Depotformulering til pralnacasanInfo
- Publication number
- DK1937221T3 DK1937221T3 DK06805947T DK06805947T DK1937221T3 DK 1937221 T3 DK1937221 T3 DK 1937221T3 DK 06805947 T DK06805947 T DK 06805947T DK 06805947 T DK06805947 T DK 06805947T DK 1937221 T3 DK1937221 T3 DK 1937221T3
- Authority
- DK
- Denmark
- Prior art keywords
- pralnacasan
- depot formulation
- type
- releases
- layer
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2086—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
- A61K9/209—Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat containing drug in at least two layers or in the core and in at least one outer layer
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102005048293A DE102005048293A1 (de) | 2005-10-08 | 2005-10-08 | Retardformulierung für Pralnacasan |
PCT/EP2006/009466 WO2007042160A1 (de) | 2005-10-08 | 2006-09-29 | Retardformulierung für pralnacasan |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1937221T3 true DK1937221T3 (da) | 2009-06-15 |
Family
ID=37764039
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK06805947T DK1937221T3 (da) | 2005-10-08 | 2006-09-29 | Depotformulering til pralnacasan |
Country Status (28)
Country | Link |
---|---|
US (1) | US8231904B2 (ja) |
EP (1) | EP1937221B1 (ja) |
JP (1) | JP2009511441A (ja) |
KR (1) | KR101362679B1 (ja) |
CN (1) | CN101277683B (ja) |
AT (1) | ATE422354T1 (ja) |
AU (1) | AU2006301573B2 (ja) |
BR (1) | BRPI0617184A2 (ja) |
CA (1) | CA2624838C (ja) |
CY (1) | CY1109131T1 (ja) |
DE (2) | DE102005048293A1 (ja) |
DK (1) | DK1937221T3 (ja) |
ES (1) | ES2322202T3 (ja) |
HK (1) | HK1124531A1 (ja) |
HR (1) | HRP20090254T1 (ja) |
IL (1) | IL190511A (ja) |
MA (1) | MA29803B1 (ja) |
ME (1) | ME01735B (ja) |
MY (1) | MY146552A (ja) |
NO (1) | NO339360B1 (ja) |
NZ (1) | NZ567268A (ja) |
PL (1) | PL1937221T3 (ja) |
PT (1) | PT1937221E (ja) |
RS (1) | RS50777B (ja) |
RU (1) | RU2419419C2 (ja) |
SI (1) | SI1937221T1 (ja) |
WO (1) | WO2007042160A1 (ja) |
ZA (1) | ZA200802031B (ja) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2011276254B2 (en) * | 2010-07-09 | 2016-11-03 | James Trinca Green | Combination immediate/delayed release delivery system for short half-life pharmaceuticals including remogliflozin |
CA2805974C (en) * | 2010-08-13 | 2019-11-26 | Euro-Celtique S.A. | Use of binders for manufacturing storage stable formulations |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6204261B1 (en) * | 1995-12-20 | 2001-03-20 | Vertex Pharmaceuticals Incorporated | Inhibitors of interleukin-1β Converting enzyme inhibitors |
US5085865A (en) * | 1989-04-12 | 1992-02-04 | Warner-Lambert Company | Sustained release pharmaceutical preparations containing an analgesic and a decongestant |
IT1264696B1 (it) * | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
FR2772615B1 (fr) * | 1997-12-23 | 2002-06-14 | Lipha | Comprime multicouche pour la liberation instantanee puis prolongee de substances actives |
UA81224C2 (uk) * | 2001-05-02 | 2007-12-25 | Euro Celtic S A | Дозована форма оксикодону та її застосування |
CN1524526A (zh) * | 2003-03-02 | 2004-09-01 | 颖 王 | 尼群地平双层缓释制剂 |
US20050013863A1 (en) * | 2003-07-18 | 2005-01-20 | Depomed, Inc., A Corporation Of The State Of California | Dual drug dosage forms with improved separation of drugs |
CN1579401A (zh) * | 2003-08-11 | 2005-02-16 | 李亦武 | 一种止咳平喘药物新剂型及制备方法 |
US7611728B2 (en) * | 2003-09-05 | 2009-11-03 | Supernus Pharmaceuticals, Inc. | Osmotic delivery of therapeutic compounds by solubility enhancement |
WO2005048979A2 (en) * | 2003-10-06 | 2005-06-02 | Torrent Pharmaceuticals Limited | Pharmaceutical composition having casing with multiple micro tablets |
WO2005051350A2 (en) * | 2003-10-28 | 2005-06-09 | Torrent Pharmaceuticals Limited | Water dispersible tablet |
-
2005
- 2005-10-08 DE DE102005048293A patent/DE102005048293A1/de not_active Ceased
-
2006
- 2006-09-29 WO PCT/EP2006/009466 patent/WO2007042160A1/de active Application Filing
- 2006-09-29 MY MYPI20080752A patent/MY146552A/en unknown
- 2006-09-29 PL PL06805947T patent/PL1937221T3/pl unknown
- 2006-09-29 CA CA2624838A patent/CA2624838C/en not_active Expired - Fee Related
- 2006-09-29 PT PT06805947T patent/PT1937221E/pt unknown
- 2006-09-29 EP EP06805947A patent/EP1937221B1/de active Active
- 2006-09-29 DK DK06805947T patent/DK1937221T3/da active
- 2006-09-29 AT AT06805947T patent/ATE422354T1/de active
- 2006-09-29 ME MEP-2009-368A patent/ME01735B/me unknown
- 2006-09-29 DE DE502006002851T patent/DE502006002851D1/de active Active
- 2006-09-29 KR KR1020087008466A patent/KR101362679B1/ko not_active IP Right Cessation
- 2006-09-29 RS RSP-2009/0174A patent/RS50777B/sr unknown
- 2006-09-29 SI SI200630266T patent/SI1937221T1/sl unknown
- 2006-09-29 RU RU2008113381/15A patent/RU2419419C2/ru not_active IP Right Cessation
- 2006-09-29 ES ES06805947T patent/ES2322202T3/es active Active
- 2006-09-29 BR BRPI0617184-2A patent/BRPI0617184A2/pt not_active IP Right Cessation
- 2006-09-29 AU AU2006301573A patent/AU2006301573B2/en not_active Ceased
- 2006-09-29 NZ NZ567268A patent/NZ567268A/en not_active IP Right Cessation
- 2006-09-29 CN CN2006800369452A patent/CN101277683B/zh not_active Expired - Fee Related
- 2006-09-29 JP JP2008533913A patent/JP2009511441A/ja active Pending
-
2008
- 2008-03-04 ZA ZA200802031A patent/ZA200802031B/xx unknown
- 2008-03-24 MA MA30779A patent/MA29803B1/fr unknown
- 2008-03-30 IL IL190511A patent/IL190511A/en not_active IP Right Cessation
- 2008-04-04 US US12/062,683 patent/US8231904B2/en not_active Expired - Fee Related
- 2008-04-21 NO NO20081896A patent/NO339360B1/no not_active IP Right Cessation
-
2009
- 2009-03-05 HK HK09102122.8A patent/HK1124531A1/xx not_active IP Right Cessation
- 2009-04-23 CY CY20091100457T patent/CY1109131T1/el unknown
- 2009-05-04 HR HR20090254T patent/HRP20090254T1/xx unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TW200740956A (en) | Organic electroluminescent devices | |
De Winter et al. | Belgium: Delegation and accountability under partitocratic rule | |
TW200704751A (en) | Novel materials for organic electroluminescent devices | |
BRPI0615347A2 (pt) | toleráncia ao estresse em plantas | |
TW200636046A (en) | Novel materials for organic electroluminescent devices | |
WO2007061939A3 (en) | Metabolite derivatives of the hdac inhibitor fk228 | |
ATE553792T1 (de) | Medizinische vorrichtungen mit verbundstoffen | |
WO2005110355A3 (en) | Personal product liquid cleansers comprising combined fatty acid and water soluble or water swellable starch structuring system | |
BRPI0515473A (pt) | ligações bicìclicas imidazol-3-yl-amina substituìdas | |
GB2453457A (en) | Indenofluorene polymer based organic semiconductor materials | |
GB2456466A (en) | Sanitizing surfaces | |
MX2009006033A (es) | Composiciones y articulos que contienen una matriz de polimero reticulado y un liquido activo inmovilizado, asi como metodos para fabricarlos. | |
TW200735438A (en) | Organic electroluminescent devices | |
NO20075702L (no) | Polymersjikt med lav fuktighet i ikke-autoklav fremgangsmate | |
DOP2010000075A (es) | Compuesto inhibidor de glicógeno fosforilasa y composicion farmaceutica del mismo | |
PE20190117A1 (es) | Compuestos de mic-1 y usos de estos | |
MX280211B (es) | Polimero, un metodo para producir el polimero y una mezcla de cemento que utiliza el mismo. | |
MX2007011493A (es) | Modalidades antiinflamatorias. | |
CR11397A (es) | Compuesto inhibidor de fosforilasa de glicogeno y composicion farmaceutica del mismo | |
WO2007120854A3 (en) | Electrically conductive polymer compositions | |
DK1937221T3 (da) | Depotformulering til pralnacasan | |
ES2351403T8 (es) | Procedimiento para reducir el contenido de dioxinas de la arcilla blanqueante | |
ATE529877T1 (de) | Mechanischer schalter mit gekrümmter doppelschicht | |
WO2008127382A3 (en) | Computational design of ribozymes | |
Russell | TAKING LONG VIEWS |